Skip to main content
SpringerLink
Log in

Adalimumab/etanercept

Myelin oligodendrocyte glycoprotein (MOG)-IgG-associated disease: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Redenbaugh V, et al. Exposure to TNF inhibitors is rare at MOGAD presentation. Journal of the Neurological Sciences 432: 15 Jan 2022. Available from: URL: https://www.elsevier.com/locate/jns

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/etanercept. Reactions Weekly 1924, 24 (2022). https://doi.org/10.1007/s40278-022-23377-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-23377-0

Search

Navigation